Pilot trial suggests structured support may help limit weight regain after GLP-1 treatment
Glucagon-like peptide-1 (GLP-1) receptor agonists are effective treatments for obesity, but discontinuation is common due to cost, insurance coverage limitations, side effects, patient preference and other factors—and often ...
Oct 7, 2026
0
13









